Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 12NIH 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2Urinary Incontinence 1Prostatic Hyperplasia 1

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Prostatectomy × Clear all
NCT02916537 2017-11-06

A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057

Cancer Targeted Technology

Phase 1 Completed
20 enrolled
Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms

NCT00937833 2014-12-29

Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling

Cook Group Incorporated

Phase NA Completed
150 enrolled 7 charts
Genitourinary

Prostatic Neoplasms, Urinary Incontinence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡